Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia four years ago. He was treated with a methylating agent While he was being treated with a hypomethylating agent, Rose researched investigational drugs being developed to treat relapsed/refractory AML.

    A New Method of Delivering Drugs Through the Blood-Brain Barrier To Treat Neurological Disorders

    Over the past decade, scientists have made many life-saving advances in all areas of medicine. They have created molecular agents to target neurodegenerative diseases. But they were stopped right there…

    Continue Reading A New Method of Delivering Drugs Through the Blood-Brain Barrier To Treat Neurological Disorders

    New Finding: Overactive Mitochondria Are Responsible for Twenty Percent of Glioblastoma Brain Cancers

    Neuroscience News recently carried an article heralding reports of researchers' finding that upwards of twenty percent of lethal glioblastoma brain cancers may be treatable by newly developed drugs. Currently, the…

    Continue Reading New Finding: Overactive Mitochondria Are Responsible for Twenty Percent of Glioblastoma Brain Cancers
    Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
    source: pixabay.com

    Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers

    While novel treatments have been rapidly emerging onto the drug scene, new treatment options for pancreatic cancer have fallen behind. But now, according to OncLive’s interview with Dr. P.A. Philip,…

    Continue Reading Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
    Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free
    source: pixabay.com

    Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free

      The initial CRISPR treatment for sickle cell disease was administered to Victoria Gray in July 2019. Victoria, a resident of Forest, Mississippi, was born with sickle cell and has…

    Continue Reading Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free
    Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma
    source: pixabay.com

    Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma

      A recent announcement by Gilead Company citing data from Kite Pharma, one of its premier companies, set out remarkable results from Kite’s Zuma-1 clinical trial. The findings confirmed that…

    Continue Reading Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma
    Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma
    qimono / Pixabay

    Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma

    According to a recent report in Cancer Network, the results from CARTITUDE-1 were well received. CARTITUDE-1 is a phase 1b/2 clinical trial of the CAR T-cell treatment, Cilta-Cel, for the…

    Continue Reading Impressive Results for Cilta-Cel to Treat Patients With Relapsed/Refractory Multiple Myeloma
    The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases
    source: pixabay.com

    The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases

      A recent article in the Encinitas Advocate heralded the dedication of Stan Crooke, n-Lorem Foundation’s CEO and founder. The nonprofit Foundation’s team acts as middlemen, working with patients who…

    Continue Reading The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases

    Pembrolizumab’s Targeting of MSI-H-dMMR Colorectal Cancers More Effective Than Chemotherapy

    The New England Journal of Medicine recently carried a report citing data from a Phase 3 clinical trial involving 307 people diagnosed with MSI-H-dMMR metastatic colorectal cancer. MSI-H (high levels…

    Continue Reading Pembrolizumab’s Targeting of MSI-H-dMMR Colorectal Cancers More Effective Than Chemotherapy

    Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients

    The United States is coping with an obesity epidemic. It is therefore critical to understand the distribution of body fat and its effect on treatment. A recent article in Healio…

    Continue Reading Study: The Relationship Between Obesity, Lung Diseases, and Pulmonary Hypertension in Transplant Patients